ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15.
Shuang WangCaixia WangYuexin HuXiao LiShan JinOuxuan LiuRui GouYuan ZhuangQian GuoXin NieLiancheng ZhuJuanjuan LiuBei LinPublished in: Journal of experimental & clinical cancer research : CR (2020)
The results showed that ZNF703 as an oncogene played an important role in the epigenetic modification of ovarian cancer proliferation, and suggested that ZNF703 as a transcription factor may become a prognostic factor and a potential therapeutic target for ovarian cancer.